On May 5, 2023, Sanbo Brain Hospital Management Group Limited, a client and portfolio company of CEC Capital, successfully debuted on the Shenzhen Stock Exchange under the ticker "301293", becoming the first private neuro-specialty hospital to go public. By the end of the trading day, Sanbo Brain Hospital's stock surged by 77.4%, closing at a price of RMB 52.5 with a total market value of approximately RMB 8.32 billion.

In the previous round of private financing announced on May 8, 2020, CEC Capital served as the exclusive financial advisor to Sanbo Brain Hospital, helping it attract investments from well-known institutions such as Taikang Asset Management, with the transaction amount exceeding RMB 800 million. This financing marked one of the largest deals in the medical services sector in recent years.

CEC’s fund also participated in the investment in Sanbo Brain Hospital, continuously empowering the hospital by bridging quality industrial chain resources, enhancing corporate strategy and operations, and coordinating communications with related governmental and enterprise departments, which facilitated Sanbo Brain Hospital's IPO process.

Founded in 2003 by renowned neurology experts Luan Guoming, Yu Chunjiang, Shi Xiang'en, and senior hospital management expert Zhang Yang, Sanbo Brain Hospital has grown over 20 years to become a well-known neuro-specialty hospital group in China. Currently, they operate six hospitals, with two under construction. They offer over 1,500 beds, serve nearly 500,000 outpatient visits annually, admit over 40,000 in-patients, and perform more than 10,000 surgeries each year – of which over 5,000 are neurosurgical procedures. Sanbo Brain Hospital, the flagship hospital affiliated with the Capital Medical University, is one of the top neuro-specialty hospitals in China. In the medical service capacity rankings released by the Beijing Health Commission, it has consistently ranked among the top in neurosurgery alongside Tiantan Hospital and Xuanwu Hospital for several years.